摘要
目的探讨"长效降血压埋植棒"在原发性高血压病中的临床应用价值。方法A组167例患者行"长效降血压埋植棒"皮下埋植。B组159例患者采用临床一线口服降压药物。对两组患者血压水平及心脑血管事件进行随访。结果Ⅰ、Ⅱ级高血压患者A组心脑血管事件发生率少于B组(P>0.05),Ⅲ级高血压患者两组心脑血管事件发生率无明显差异。结论"长效降血压埋植棒"皮下埋植可以获得和坚持口服降压药物相似的血压降低幅度,更为稳定地控制血压,降低心脑血管事件发生率。
Objective To dicuss clinical value ＂long-lasting blood pressure rod implant,＂ in hypertension. Methods A group of 167 cases of patients with ＂long-lasting blood pressure rod implant,＂ subcutaneous implants. 159 cases of group B patients with clinical use of oral first-line antihypertensive drug. Results Ⅰ, Ⅱ Class A group of high blood pressure in patients with cardiovascular and cerebrovascular events incidence of group B is less than （P〉 0.05）,Ⅲ-class high blood pressure in patients with two groups of cardiovascular and cerebrovascular events was no significant difference. Conculsion ＂Long-rod implant blood pressure,＂ can be implanted subcutaneously and adhere to the relief of oral drugs to lower blood pressure similar to the margin, more stable blood pressure control, reduce cardiovascular event rate.
出处
《中国现代医生》
2008年第32期44-45,共2页
China Modern Doctor
关键词
高血压
长效
皮下埋植
High blood pressure
Long lasting
Subcutaneous implants
